Navigation Links
Investor Relations Firm Access IR/PR and The Communications Strategy Group Announce Strategic Alliance
Date:10/29/2009

Access IR/PR, a San Diego-based investor and public relations firm, and The Communications Strategy Group Inc. (CSG), a corporate/financial communications consultancy based in Boston, have formed a strategic alliance. The alliance expands the senior-level talent and services available to both firms' clients and provides extended access to key financial, investor and media communities in the U.S. and abroad as well as assistance with capital formation, joint ventures and corporate partnering.

San Diego, CA, and Boston, MA (PRWEB) October 29, 2009 -- Access IR/PR, a San Diego-based investor and public relations firm, and The Communications Strategy Group Inc. (CSG), a corporate/financial communications consultancy based in Boston, have formed a strategic alliance. The alliance expands the senior-level talent and services available to both firms' clients and provides extended access to key financial, investor and media communities in the U.S. and abroad as well as assistance with capital formation, joint ventures and corporate partnering.

Access IR/PR
Access IR/PR provides strategic, senior-level investor relations and corporate communications counsel and support to public and private companies in the biotechnology, medical device and emerging technology industries. The firm is led by Scott A. Rieger, who previously served as Vice President, Corporate Communications and Investor Relations at Hollis-Eden Pharmaceuticals (NASDAQ: HEPH), and Andrew Wiseman, Ph.D., formerly Senior Director of Investor Relations at La Jolla Pharmaceutical Company (NASDAQ: LJPC).

Access IR/PR's services include counsel on corporate message development; drafting and production of communications tools and materials; execution of targeted investor, media, key opinion leader and industry outreach programs; development and execution of appropriate internal systems, policies and procedures; and training and counsel on current communications practices, trends and issues. Private company consulting services support IPO and transaction oriented exit strategies, including access to and communications with appropriate investors and strategic partners. For more information on Access IR/PR, see accessirpr.com.

The Communications Strategy Group Inc.
CSG, led by Edward D. Agne, provides a full range of communications and international business development services to emerging companies in advanced technologies, life sciences, biotechnology and medical technology. Specialized expertise areas include media relations, mergers & acquisitions communications, crisis management and employee relations. CSG operates through a team of consultants with backgrounds in large communications agencies, government, university-level teaching and major media.

Mr. Agne founded CSG, having served as an officer at Burson-Marsteller, a global communications and lobbying consultancy, and Connell Limited Partnership, a privately owned industrial conglomerate based in Boston. Mr. Agne is active in the Massachusetts Biotechnology Council, the Massachusetts Medical Device Industry Council, the British American Business Council of New England and the three major UK biotech/medtech regions of Oxford, Cambridge and London. For more information on The Communications Strategy Group Inc., see http://www.comstratgroup.com.

###

Read the full story at http://www.prweb.com/releases/2009/10/prweb3127534.htm.


'/>"/>
Source: PRWeb
Copyright©2009 Vocus, Inc.
All rights reserved

Related biology technology :

1. Cell Therapeutics, Inc.s (CTI) Presentation at BIO Investor Forum to be Webcast
2. Soligenix to Present at 8th Annual BIO Investor Forum
3. Media Advisory - Oncolytics Biotech Inc. to Present at BIO Investor Forum 2009
4. AEterna Zentaris Receives US$5.5 Million from Institutional Investors
5. Epeius Biotechnologies to Partner at BIO Investor Forum
6. Transdel Pharmaceuticals to Present at Two Investor Conferences
7. SENOMYX TO WEBCAST CORPORATE PRESENTATION AT THE 2009 BIOCOM INVESTOR CONFERENCE
8. AEterna Zentaris to Raise US$5.5 Million from Institutional Investors at US$1.20 Per Share
9. Advanced Life Sciences to Present at 8th Annual BIO Investor Forum
10. Accuray Incorporated to Host Investor and Analyst Meeting at ASTRO
11. New Oxygen Biotherapeutics, Inc. Investor Presentation Available on Company Website
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/24/2017)... 24, 2017   Sienna Biopharmaceuticals, Inc. , a ... announced that Richard Peterson will join the ... Peterson, who brings more than two decades of ... who is retiring at the end of April but ... Peterson joins Sienna from Novan, Inc., where he served ...
(Date:3/23/2017)... 2017 Research and Markets has announced ... report to their offering. ... The Global Market for Bioproducts Should ... at a CAGR of 8.9%, This research ... into seven major product segments: bio-derived chemicals, biofuels, pharmaceuticals (biodrugs ...
(Date:3/23/2017)... March 23, 2017  BioPharmX Corporation (NYSE MKT: ... the dermatology market, today reported financial results for ... and will provide an update on the company,s ... "We are pleased to report that ... BioPharmX," said President Anja Krammer. "We achieved key ...
(Date:3/23/2017)... According to a report by Transparency Market Research (TMR), ... the presence of a large pool of participants; however, only a ... Sigma-Aldrich, compete with each other in this market. With Proliant being ... of this market in 2016.  ... As of now, a large number of vendors are ...
Breaking Biology Technology:
(Date:2/13/2017)... 2017  RSA Conference -- RSA, a Dell Technologies ... to enhance fraud detection and investigation across digital ... Fraud & Risk Intelligence Suite. The new platform ... insights from internal and external sources as well ... customers from targeted cybercrime attacks. "Fraudsters ...
(Date:2/10/2017)... -- Research and Markets has announced the ... Scientific and Commercial Aspects" to their offering. ... Biomarkers play ... therapy for selection of treatment as well for monitoring the ... disease in modern medicine. Biochip/microarray technologies and next generation sequencing ...
(Date:2/8/2017)... , Feb. 8, 2017 About Voice ... voice to match it against a stored voiceprint ... as pitch, cadence, and tone are compared to ... minimal hardware installation, as most PCs already have ... different transactions. Voice recognition biometrics are most likely ...
Breaking Biology News(10 mins):